Patents by Inventor Geoffrey A. Kruse

Geoffrey A. Kruse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11305057
    Abstract: Embodiments of the present disclosure enable a user-wearable infusion pump that may have a limited user interface including no display to execute and provide feedback on a number of functions. A remote control device having a display can be used to control the infusion pump. The infusion pump can include one or more indicator lights that can be indicate different statuses with different light patterns. The remote control device can include a display screen that provides further information relating to various pump statuses.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: April 19, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael Michaud, Geoffrey A. Kruse, Jason Farnan, Ian Cadieux, Anthony Elbancol, Preston Sobel, David Nguyen, Robert Eastridge, Kennen Dietz, Caleb Butler
  • Publication number: 20220104133
    Abstract: A battery-powered infusion pump for delivery of insulin or other medicament may collect and store data related to the pump. The infusion pump can communicate some or all of the stored data to another device, and control the timing and amount of data communicated in order to conserve battery life.
    Type: Application
    Filed: December 13, 2021
    Publication date: March 31, 2022
    Inventor: Geoffrey A. Kruse
  • Patent number: 11285263
    Abstract: Embodiments are directed to portable infusion devices, systems, and methods of using the same for dispensing materials. In some cases, the devices, systems and methods may be used for infusing a material such as medicament, e.g., insulin, into a body in need thereof.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: March 29, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Paul M. DiPerna, Michael J. Rosinko, Geoffrey A. Kruse, Thomas R. Ulrich, Christopher Dabrow, Mark Williamson, Brian Bureson, Kathryn Rieger
  • Publication number: 20220062553
    Abstract: Apparatuses and methods for transitioning to sleep mode or otherwise modified glucose target range in automated insulin delivery systems. For example, sleep mode can include a lower glucose target and/or lower and narrower glucose target range because of fewer variables that affect glucose values during sleep such as eating and exercise. Due to increased stability provided by the sleep mode target range, it is desirable to transition to the sleep mode target range as quickly as possible, while ensuring the transition is done safely and does not risk low glucose or hypoglycemia by too quickly switching to the lower and narrower target range. Systems and methods disclosed herein therefore provide various approaches for safely and quickly transitioning to sleep mode or other modified target ranges in order to improve time in range by being more aggressive to get to the lower sleep mode or other target faster without risking hypoglycemia.
    Type: Application
    Filed: August 27, 2021
    Publication date: March 3, 2022
    Inventors: Alexandra Elena Constantin, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Virginia S. Lu, Garrett Marin
  • Publication number: 20220001106
    Abstract: Embodiments are directed to portable infusion devices, systems, and methods of using the same for dispensing materials. In some cases, the devices, systems and methods may be used for infusing a material such as medicament, e.g., insulin, into a body in need thereof.
    Type: Application
    Filed: September 17, 2021
    Publication date: January 6, 2022
    Inventors: Paul M. DiPerna, Michael J. Rosinko, Geoffrey A. Kruse, Thomas R. Ulrich, Christopher Dabrow, Mark Williamson, Brian Bureson, Kathryn Rieger
  • Patent number: 11218968
    Abstract: A battery-powered infusion pump for delivery of insulin or other medicament may collect and store data related to the pump. The infusion pump can communicate some or all of the stored data to another device, and control the timing and amount of data communicated in order to conserve battery life.
    Type: Grant
    Filed: November 6, 2019
    Date of Patent: January 4, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Geoffrey A. Kruse
  • Publication number: 20210368442
    Abstract: Disclosed herein are methods for establishing communication protocols between wireless devices in infusion pump systems. Infusion pump systems can include a number of components capable of wireless communication with one or more other components including an infusion pump, a continuous glucose monitoring (CGM) system, a smartphone or other multi-purpose consumer electronic device and/or a dedicated remote controller for the infusion pump. Communications among these devices can be coordinated to increase efficiency and conserve battery power.
    Type: Application
    Filed: August 5, 2021
    Publication date: November 25, 2021
    Inventors: Geoffrey A. Kruse, Michael Michaud
  • Patent number: 11135362
    Abstract: Embodiments are directed to portable infusion devices, systems, and methods of using the same for dispensing materials. In some cases, the devices, systems and methods may be used for infusing a material such as medicament, e.g., insulin, into a body in need thereof.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: October 5, 2021
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Paul M. DiPerna, Michael J. Rosinko, Geoffrey A. Kruse, Thomas R. Ulrich, Christopher Dabrow, Mark Williamson, Brian Bureson, Kathryn Rieger
  • Patent number: 11109316
    Abstract: Disclosed herein are methods for establishing communication protocols between wireless devices in infusion pump systems. Infusion pump systems can include a number of components capable of wireless communication with one or more other components including an infusion pump, a continuous glucose monitoring (CGM) system, a smartphone or other multi-purpose consumer electronic device and/or a dedicated remote controller for the infusion pump. Communications among these devices can be coordinated to increase efficiency and conserve battery power.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: August 31, 2021
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Geoffrey A. Kruse, Michael Michaud
  • Publication number: 20210154405
    Abstract: Disclosed herein are systems and methods for mitigating the risk of insulin stacking in automated insulin delivery systems. In AID systems configured to both automatically calculate insulin delivery based on glucose levels and receive manual programming of meal boluses configured to counteract carbohydrates in a meal, insulin stacking can result if the system automatically increases insulin delivery based on a rise in glucose levels in response to consumption of a meal and the user later programs a meal bolus for the meal. The risk of such double dosing is mitigated by the systems and methods disclosed herein by enabling the system to account for recent automated insulin increases when a meal bolus is programmed.
    Type: Application
    Filed: November 19, 2020
    Publication date: May 27, 2021
    Inventors: Jacob Kearns, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Scott Leas, Betsy Dokken, Garrett Marin, Nicholas Sherer
  • Publication number: 20210128825
    Abstract: Embodiments of the present disclosure enable a user-wearable infusion pump that may have a limited user interface including no display to be paired with a remote control device that can include a remote consumer electronic device such as a smartphone and/or a dedicated remote controller.
    Type: Application
    Filed: January 11, 2021
    Publication date: May 6, 2021
    Inventors: Jason Farnan, Zion Greenlee, Geoffrey A. Kruse, Michael Michaud
  • Publication number: 20210113766
    Abstract: Disclosed herein are systems and methods incorporating an ambulatory infusion pump and a CGM. These systems that can include software and related methods to provide improved automated insulin delivery algorithms that enable the algorithms to safely continue delivering insulin for some time periods of missing or known inaccurate glucose values.
    Type: Application
    Filed: October 20, 2020
    Publication date: April 22, 2021
    Inventors: Jacob Kearns, Michael Michaud, Geoffrey A. Kruse, Garrett Marin, Paul Harris, Thomas R. Ulrich, Brendan Nichols
  • Patent number: 10888655
    Abstract: Embodiments of the present disclosure enable a user-wearable infusion pump that may have a limited user interface including no display to be paired with a remote control device that can include a remote consumer electronic device such as a smartphone and/or a dedicated remote controller.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: January 12, 2021
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Jason Farnan, Zion Greenlee, Geoffrey A. Kruse, Michael Michaud
  • Publication number: 20210001044
    Abstract: Disclosed herein are apparatuses and methods incorporating an infusion pump and a CGM that can include software that automatically populates a blood glucose section of a bolus calculator with a most recent valid CGM value. The software can additionally be programmed to automatically populate the bolus calculator with a single CGM reading only when one or more predefined conditions are met that aid in mitigating the risk of inaccurate and/or invalid single CGM readings.
    Type: Application
    Filed: July 6, 2020
    Publication date: January 7, 2021
    Inventors: Michael Michaud, Garrett Marin, Geoffrey A. Kruse, Jacob Kearns, Thomas R. Ulrich, Trevor Denbo, David Berger
  • Publication number: 20200368430
    Abstract: Disclosed herein are apparatuses and methods that account for exercise in closed loop insulin delivery systems. Rather than increasing a target insulin on board (IOB) as glucose levels rise, which would increase insulin delivery to address the raised glucose levels, when a user indicates that the user will be exercising raised glucose levels are addressed by reducing the target IOB within the closed loop algorithm. By reducing the target IOB, the algorithm responds less aggressively to pre-exercise food, and does not build up the IOB that can cause dangerously low glucose levels once the exercise also begins lowering glucose levels.
    Type: Application
    Filed: May 20, 2020
    Publication date: November 26, 2020
    Inventors: Thomas R. Ulrich, Michael Michaud, Geoffrey A. Kruse, Paul Harris, Garrett Marin
  • Publication number: 20200372995
    Abstract: Disclosed herein are methods for establishing communication protocols between wireless devices in infusion pump systems. Infusion pump systems can include a number of components capable of wireless communication with one or more other components including an infusion pump, a continuous glucose monitoring (CGM) system, a smartphone or other remote consumer electronic device and/or a dedicated remote controller for the infusion pump. The present disclosure provides various methods for simplifying connections among these devices.
    Type: Application
    Filed: May 21, 2020
    Publication date: November 26, 2020
    Inventors: Geoffrey A. Kruse, Thomas R. Ulrich, Jason Farnan, Robert Eastridge, Michael Michaud, Dwight Lee
  • Publication number: 20200329433
    Abstract: Disclosed herein are methods for establishing communication protocols between wireless devices in infusion pump systems. Infusion pump systems can include a number of components capable of wireless communication with one or more other components including an infusion pump, a continuous glucose monitoring (CGM) system, a smartphone or other multi-purpose consumer electronic device and/or a dedicated remote controller for the infusion pump. Communications among these devices can be coordinated to increase efficiency and conserve battery power.
    Type: Application
    Filed: June 25, 2020
    Publication date: October 15, 2020
    Inventors: Geoffrey A. Kruse, Michael Michaud
  • Publication number: 20200306445
    Abstract: Embodiments of the present disclosure enable a user-wearable infusion pump that may have a limited user interface including no display to execute and provide feedback on a number of functions. A remote control device having a display can be used to control the infusion pump. The infusion pump can include one or more indicator lights that can be indicate different statuses with different light patterns. The remote control device can include a display screen that provides further information relating to various pump statuses.
    Type: Application
    Filed: March 26, 2020
    Publication date: October 1, 2020
    Inventors: Michael Michaud, Geoffrey A. Kruse, Jason Farnan, Ian Cadieux, Anthony Elbancol, Preston Sobel, David Nguyen, Robert Eastridge, Kennen Dietz, Caleb Butler
  • Publication number: 20200261644
    Abstract: Embodiments of the present disclosure enable a user-wearable infusion pump that may have a limited user interface including no display to be paired with a remote control device that can include a remote consumer electronic device such as a smartphone and/or a dedicated remote controller.
    Type: Application
    Filed: July 10, 2019
    Publication date: August 20, 2020
    Inventors: Jason Farnan, Zion Greenlee, Geoffrey A. Kruse, Michael Michaud
  • Publication number: 20200261649
    Abstract: Disclosed herein are apparatuses and methods for improved use of infusion sites for infusion pumps. Apparatuses and methods for delivery of medicaments such as insulin disclosed herein can increase the effectiveness of therapy by more accurately determining when an infusion site is no longer absorbing insulin at an acceptable rate as well as determining the effectiveness of different infusion sites on the body with respect to each other and over time.
    Type: Application
    Filed: February 18, 2020
    Publication date: August 20, 2020
    Inventors: Michael Michaud, Geoffrey A. Kruse